Search results
Here's the 1 Key Reason You Might Want to Buy CRISPR Therapeutics Stock on the Dip
Motley Fool via Yahoo Finance· 6 months agoIt's now a new ballgame for CRISPR Therapeutics (NASDAQ: CRSP). The company, along with its big...
Here's Why CRISPR Therapeutics Stock Climbed 34% in February
Motley Fool via Yahoo Finance· 3 months agoCRISPR Therapeutics (NASDAQ: CRSP) was a standout in the market last month as its shares charged 34%...
Can CRISPR Therapeutics Stock Double in 5 Years? Here's What It Would Take.
Motley Fool· 7 months agoCRISPR Therapeutics (NASDAQ: CRSP) has reached a very exciting point in its story. The biotech...
Institutional investors control 68% of CRISPR Therapeutics AG (NASDAQ:CRSP) and were rewarded last...
Simply Wall St. via Yahoo Finance· 4 months agoKey Insights Given the large stake in the stock by institutions, CRISPR Therapeutics' stock price...
Why CRISPR Therapeutics Stock Is Jumping Again Today
Motley Fool· 7 months agoShares of CRISPR Therapeutics (NASDAQ: CRSP) were jumping 10.1% higher as of 10:58 a.m. ET on Friday. The solid move followed Thursday's gain of more...
CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know
Zacks via Yahoo Finance· 2 months agoCRISPR Therapeutics AG (CRSP) closed at $57.96 in the latest trading session, marking a -1.29% move...
Industry Analysts Just Upgraded Their CRISPR Therapeutics AG (NASDAQ:CRSP) Revenue Forecasts By -28%
Simply Wall St. via Yahoo Finance· 2 years agoShareholders in CRISPR Therapeutics AG (NASDAQ:CRSP) may be thrilled to learn that the analysts have...
After This Landmark Win, Is CRISPR Therapeutics a Buy?
Motley Fool via Yahoo Finance· 6 months agoCRISPR Therapeutics (NASDAQ: CRSP) scored a major win in recent days, earning the world's first...
If You Invested $5,000 in CRISPR Therapeutics in January, This Is How Much You Would Have Today
Motley Fool· 6 months agoCRISPR Therapeutics' (NASDAQ: CRSP) stock has soared this year -- and for good reason. The biotech...
Where Will CRISPR Therapeutics Be in 5 Years?
Motley Fool via Yahoo Finance· 6 months agoCRISPR Therapeutics (NASDAQ: CRSP) received great news last week. Its gene-editing therapy, which it has been developing with Vertex Pharmaceuticals,...
